IGF1 and attention deficit-hyperactivity disorder: The criterion for eligibility was initially set as “articles that measured IGF peripheral members in humans with an official diagnosis of a psychiatric disorder (SZ, MDD, BD, BPD, OCD, ASD or ADHD)”.